Skip to main content
. 2015 Oct 20;29(5):451–459. doi: 10.1007/s10557-015-6618-1

Fig. 1.

Fig. 1

Flow of patients through the glycometabolic intervention as adjunct to primary coronary intervention in the ST-segment elevation myocardial infarction (GIPS-III) trial